NCT02875951View on ClinicalTrials.gov

Investigating Patient Satisfaction With Oral Anti-cancer Treatment in Patients With Hormone-receptor Positive, HER2-receptor Negative, Advanced Breast Cancer

UnknownOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
ER Positive, HER2 Negative Breast Cancer Neoplasms
Trial Locations (1)

3000

RECRUITING

Katholieke Universiteit Leuven - Clinical Pharmacology and Pharmacotherapeutics, Leuven

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

KU Leuven

OTHER